文献速递腹部泌尿生殖技术与安全MR

减重手术后棕色、白色、肝脏及胰腺脂肪的变化:MRI评估

Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI.
PubMed 文献 · Eur Radiol · 2018-07-30

本研究对12例病态肥胖患者(女8例,男4例,年龄45.4岁,BMI 35.2 kg/m2)在减重手术前及术后6、12个月行MRI,测量锁骨上棕色脂肪、腹部白色脂肪、肝脏甘油三酯及胰腺脂肪。结果显示BMI、肝内甘油三酯、皮下及内脏脂肪在术后6个月显著降低,胰腺脂肪在12个月显著降低,棕色脂肪体积、脂肪分数及T2*值无显著变化,非酒精性脂肪性肝病消退。

要点

  • 减重术后6个月肝内甘油三酯显著降低,非酒精性脂肪性肝病消退,阅片时注意肝脏脂肪分数变化。
  • 术后6个月皮下和内脏白色脂肪体积显著减少,棕色脂肪体积、脂肪分数及T2*值无显著变化。
  • 胰腺脂肪在术后12个月显著降低,而6个月时尚未达统计学显著。

核心结论

  • 减重手术有效减重,主要源于腹部白色脂肪减少;肝脏和胰腺脂肪降至阈值以下,可能因游离脂肪酸减少;棕色脂肪体积、脂肪分数及T2*无显著变化,可能因手术本身未改变患者代谢谱。

研究设计与样本

  • 前瞻性观察性研究,纳入12例病态肥胖患者(女8例,男4例),在基线及术后6个月、12个月行共三次MRI,采集水、脂肪、脂肪分数及T2*图像序列,用自研算法测量锁骨上棕色脂肪和腹部白色脂肪,用MR波谱测量肝内甘油三酯,用感兴趣区法测量胰腺脂肪;采用Friedman检验和Wilcoxon符号秩检验比较脂肪含量,显著性水平设为p=0.017(0.05/3)。

诊断标准与关键数值

  • 非酒精性脂肪性肝病的阈值设为5.56%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To study the change in brown and white adipose tissue (BAT and WAT), as well as fat content in the liver and pancreas, in patients with morbid obesity before and after bariatric surgery.

METHODS: Twelve patients with morbid obesity (F=8, M=4, age: 45.4 years (38.4-51.2), BMI: 35.2 kg/m2 (32.5-38.6)) underwent pre-op MRI at baseline and two post-op scans at 6-month and 12-month intervals after bariatric surgery. Co-registered water, fat, fat-fraction and T2* image series were acquired. Supraclavicular BAT and abdominal WAT were measured using in-house algorithms. Intrahepatic triglyceride (IHTG) was measured using MR spectroscopy and pancreatic fat was measured using a region-of-interest approach. Fat contents were compared between baseline and the first and second 6-month intervals using non-parametric analysis of Friedman's test and Wilcoxon's signed-rank test. Level of significance was selected at p=0.017 (0.05/3). Threshold of non-alcoholic fatty liver disease was set at 5.56%.

RESULTS: Results indicated that BMI (p=0.005), IHTG (p=0.005), and subcutaneous (p=0.005) and visceral adipose tissues (p=0.005) were significantly reduced 6 months after surgery. Pancreatic fat (p=0.009) was significantly reduced at 12 months. Most reduction became stable between the 6-month and 12-month interval. No significant difference was observed in BAT volume, fat-fraction and T2* values.

CONCLUSION: The results of this study suggest that bariatric surgery effectively reduced weight, mainly as a result of the reduction of abdominal WAT. Liver and pancreatic fat were deceased below the threshold possibly due to the reduction of free fatty acid. BAT volume, fat-fraction and T2* showed no significant changes, probably because surgery itself might not have altered the metabolic profile of the patients.

KEY POINTS: • No significant changes were observed in fat-fraction, T2* and volume of brown adipose tissue after bariatric surgery. • Non-alcoholic fatty liver disease was resolved after surgery. • Abdominal white fat and liver fat were significantly reduced 6 months after surgery and become stable between 6 and 12 months while pancreatic fat was significantly reduced between 0 and 12 months.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Hui SCN, Wong SKH, Ai Q, et al. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI. Eur Radiol. 2018. PMID: 30062524. doi:10.1007/s00330-018-5611-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。